Key statistics
On Monday, Allogene Therapeutics Inc (ALLO:NSQ) closed at 2.65, -5.36% below its 52-week high of 2.80, set on Feb 27, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.63 |
|---|---|
| High | 2.73 |
| Low | 2.54 |
| Bid | 2.66 |
| Offer | 2.70 |
| Previous close | 2.78 |
| Average volume | 6.36m |
|---|---|
| Shares outstanding | 224.73m |
| Free float | 168.64m |
| P/E (TTM) | -- |
| Market cap | 624.75m USD |
| EPS (TTM) | -0.981 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Allogene Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
- Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T
- Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
- Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update
- Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
- Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update
- Allogene Therapeutics Announces Participation in Upcoming Investor Conference
- Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update
More ▼
